Sara Palma Gullì

Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19

Alessandro Russo, Andrea Bruni, Sara Palma Gullì et al. · International Journal of Antimicrobial Agents · 2023 · 79 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience

Alessandro Russo, Sara Palma Gullì, A D’Avino et al. · International Journal of Antimicrobial Agents · 2024 · 19 citations

Life Sciences, Infectious Diseases, Microbiology +17

Persistence of SARS‐CoV‐2 infection and viral <i>intra</i> ‐ and <i>inter</i> ‐host evolution in COVID‐19 hospitalized patients

Grazia Pavia, Angela Quirino, Nadia Marascio et al. · Journal of Medical Virology · 2024 · 17 citations · Full text

Life Sciences, Evolutionary Biology, Infectious Diseases +17

Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study

Salvatore Rotundo, Lavinia Berardelli, Sara Palma Gullì et al. · BMC Infectious Diseases · 2024 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study

Alessandro Russo, Francesca Serapide, Francesco Alessandri et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2025 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17